Aims and Scope
Instructions for Authors
Instructions for Reviewers
Ahead of Print
Most Read Articles
Most Cited Articles
Korean J Intern Med Search
> Browse Articles > Korean J Intern Med Search
Daclatasvir and asunaprevir combination therapy for patients with chronic hepatitis C virus genotype 1b infection in real world
Jae Young Oh, Byung Seok Kim, Chang Hyeong Lee, Jeong Eun Song, Heon Ju Lee, Jung Gil Park, Jae Seok Hwang, Woo Jin Chung, Byoung Kuk Jang, Young Oh Kweon, Won Young Tak, Soo Young Park, Se Young Jang, Jeong Ill Suh, Sang Gyu Kwak
Korean J Intern Med.
2019;34(4):794-801. Published online May 25, 2018
Cited By 1
Background/Aims: Previous studies have reported a high rate of sustained virologic response (SVR) and a low rate of serious adverse events with the use of daclatasvir (DCV) and asunaprevir (ASV) combination therapy. We evaluated the efficacy and safety of DCV and ASV combination therapy for patient..
101-2501, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-2271-6792 Fax: +82-2-790-0993 E-mail:
Copyright © 2019 The Korean Association of Internal Medicine. All rights reserved.
For Authors and Reviewers